QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $8,676,000 | -4.2% | 309,623 | -6.2% | 0.03% | -7.1% |
Q3 2016 | $9,056,000 | +24.7% | 330,047 | -0.9% | 0.03% | +21.7% |
Q2 2016 | $7,260,000 | +11.2% | 332,877 | +13.9% | 0.02% | -8.0% |
Q1 2016 | $6,527,000 | -22.7% | 292,150 | -4.3% | 0.02% | -19.4% |
Q4 2015 | $8,445,000 | +7.2% | 305,410 | 0.0% | 0.03% | +3.3% |
Q3 2015 | $7,880,000 | +4.1% | 305,410 | 0.0% | 0.03% | +11.1% |
Q2 2015 | $7,571,000 | -1.6% | 305,410 | 0.0% | 0.03% | +3.8% |
Q1 2015 | $7,696,000 | +5.4% | 305,410 | -1.9% | 0.03% | +13.0% |
Q4 2014 | $7,303,000 | +3.0% | 311,300 | -0.0% | 0.02% | 0.0% |
Q3 2014 | $7,091,000 | -8.3% | 311,435 | -1.5% | 0.02% | -8.0% |
Q2 2014 | $7,731,000 | +15.7% | 316,216 | -0.2% | 0.02% | +13.6% |
Q1 2014 | $6,680,000 | -17.3% | 316,748 | -6.7% | 0.02% | -8.3% |
Q4 2013 | $8,081,000 | +11.4% | 339,402 | +0.1% | 0.02% | +4.3% |
Q3 2013 | $7,257,000 | +11.7% | 339,107 | +3.9% | 0.02% | +4.5% |
Q2 2013 | $6,499,000 | – | 326,441 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |